RxDoctor Payments Data

Kenny Lin, MD

Otology & Neurotology · Houston, TXNPI 1548502925

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,844 of the $2,368 with a category attached, or 77.9%. 11 manufacturers reported payments, led by Cochlear Americas at 33.5% of the total.

$2,368in general payments, 2019–2025

Across 29 payments — averaging $81.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$793
  • Acera Surgical, Inc.$320
  • Advanced Bionics, LLC$272
  • Kerecis Limited$237
  • Medtronic$223
  • Sanofi$169
  • plus $355 from 5 others

What the payments were for

  • Travel & lodging$52422%
  • Food & beverage$1,84478%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,368 in reported general payments places this provider in the 60th percentile of 33 otology & neurotology providers in Texas.

See all otology & neurotology providers in Texas

Medicare billing

Part B allowed, 2024
$229,737
Medicare patients
741
Services billed
2,261

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth70$8,107
Azelastine Hcl150$3,256
Fluocinolone Acetonide Oil33$1,334
Fluticasone Propionate94$1,201
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort18$859
Dexamethasone Sodium Phosphate12$700
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid75$612
Ofloxacin20$572
Methylprednisolone58$397
Meclizine Hcl16$355
Acetaminophen-CodeineAcetaminophen With Codeine79$320
Cephalexin50$276
Amitriptyline Hcl32$172
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$158
Topiramate16$127

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →